NCT04191785View on ClinicalTrials.gov

Evaluation of the Plasmatic NGAL as a Predictive Marker of Renal Injury in Children With Urinary Infection. (Perf-NGAL-IU)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

April 20, 2023

Study Completion Date

October 26, 2023

Conditions
Urinary Tract Infections
Interventions
DIAGNOSTIC_TEST

plasmatic NGAl and MRI

Determination of plasma NGAL protein during routine blood test Realization of a reno vesical MRI at 48 hours of inclusion

Trial Locations (1)

Unknown

Fondation Lenval Hopitaux Pediatriques de Nice Chu Lenval, Nice

All Listed Sponsors
lead

Fondation Lenval

OTHER

NCT04191785 - Evaluation of the Plasmatic NGAL as a Predictive Marker of Renal Injury in Children With Urinary Infection. (Perf-NGAL-IU) | Biotech Hunter | Biotech Hunter